Dr. Agarwal Healthcare IPO aims to raise Rs 3027.26 Crores through this offering, with a fresh issue of Rs 300 Crores and 2727.26 Crore through offer for sale. The face value of the equity shares Rs 1 each, with a price band ranging from Rs 382 to Rs 402 per share. The minimum order quantity is 35 shares, translating to a minimum investment of Rs 14070. Retail quota is not less then 35%, QIB is not more then 50% and HNI is not less then 15%.Dr Agarwal Healthcare IPO List on NSE on 5 February 2025
The book running lead managers for this IPO are Kotak Mahindra Capital Company Limited, Morgan Stanley India Company Private Limited, Jefferies India Private Limited and Motilal Oswal Investment Advisors Limited ensuring a smooth and efficient process for all investors. Axis Bank Limited and ICICI Bank Limited have been appointed as the sponsor banks, providing support for the IPO’s financial transactions. Additionally, the official registrar for the IPO is KFin Technologies Limited, offering reliable services for all share-related processes.
Dr. Agarwal Healthcare IPO Key Dates
| IPO Open Date | 29-Jan 2025 |
| IPO Close Date | 31-Jan-2025 |
| Allotment | 03-Jan-2025 |
| Credit of Share | 04-Feb-2025 |
| IPO Listing | 05-Feb-2025 |
Dr. Agarwal Healthcare IPO Financial Information
| 30-Sep-2024 | 31-Mar-2024 | 31-Mar-2023 | 31-Mar-2022 | |
|---|---|---|---|---|
| Assents | 3393.4 | 2752.8 | 1825.1 | 1026.1 |
| Borrowing | 373.6 | 387.7 | 356.1 | 290.1 |
| Reserve & s. | 1509.1 | 1365.8 | 652.6 | 236.2 |
| Income | 837.9 | 1376.4 | 1031.4 | 713.7 |
| Expensess | 777.5 | 1235.8 | 947.9 | 657.0 |
| PBT | 60.3 | 140.5 | 83.5 | 56.7 |
| PAT | 39.5 | 95.0 | 103.2 | 43.1 |
Dr. Agarwals Healthcare IPO Key Indicator
All the figures provided below are based on the financial statement as of march 31 2024
(D)- Diluted
(Y)- Year on Year
| EPS (D) | 3.13 |
| RoNW | 6.21% |
| NAV | 50.53 |
| PAT Margin | 6.90 |
| P/E (D) | 122.04 |
| ROE | 9.33% |
| ROCE | 14.61% |
| Revenue Growth (Y) | 30.86% |
Dr. Agarwal Healthcare IPO Peer Comparison
| P/E | EPS | RoNW | NAV | |
|---|---|---|---|---|
| Dr. Agarwal | – | 3.14 | 6.21% | 50.53 |
| Apollo Hospitals | 107.11 | 62.50 | 12.97% | 481.93 |
| Max Healthcare | 95.88 | 10.89 | 12.58% | 86.54 |
| Fortis Healthcare | 82.11 | 7.93 | 7.82% | 101.48 |
| Global Health | 57.49 | 17.80 | 16.46% | 108.17 |
| Narayana | 33.14 | 38.86 | 27.37% | 141.98 |
| Krishna Institute | 79.79 | 7.75 | 16.96% | 228.47 |
| Aster DM | 136.07 | 3.60 | 3.63% | 71.62 |
Management of the Company
| Name | Role |
|---|---|
| Dr. Amar Agarwal | Chairperson & Non-Executive Director |
| Dr. Adil Agarwal | Whole-time Director & CEO |
| Dr. Anosh Agarwal | Whole-time Director & CO |
| Sanjay Dharambir Anand | Non-Executive Independent Director |
| Venkatraman Balakrishna | Non-Executive Independent Director |
Object of the Issue
The Company proposes to utilise the Net Proceeds from the Fresh Issue towards funding of the following objects:
1. Repayment/prepayment, in part or full, of certain of our borrowings; and
2. General corporate purposes and unidentified inorganic acquisition
BOOK RUNNING LEAD MANAGERS
Kotak Mahindra Capital Company Limited
27BKC, 1st Floor, Plot No. C – 27
”G” Block, Bandra Kurla Complex
Bandra (East), Mumbai – 400 051
Maharashtra, India
Tel: +91 22 4336 0000
Email: dragarwal.ipo@kotak.com
Website: https://investmentbank.kotak.com
Investor Grievance ID: kmccredressal@kotak.com
Contact Person: Ganesh Rane
SEBI Registration Number: INM000008704
Morgan Stanley India Company Private Limited Altimus, Level 39 & 40, Pandurang Budhkar Marg, Worli Mumbai 400013 Maharashtra, India Tel: +91 22 6118 1000 Email: dragarwalipo@morganstanley.com Website: www.morganstanley.com/india Investor Grievance ID: investors_india@morganstanley.com Contact Person: Param Purohit SEBI Registration Number: INM000011203
REGISTRAR TO THE OFFER
KFin Technologies Limited
Selenium Tower B, Plot No. 31 and 32, Financial
District, Nanakramguda, Serilingampally
Hyderabad-500 032, Telangana, India
Tel: +91 40 6716 2222/18003094001
E-mail: ahcl.ipo@kfintech.com
Investor grievance e-mail:
einward.ris@kfintech.com
Website: www.kfintech.com
Contact Person: M. Murali Krishna
SEBI Registration No.: INR000000221
For more upcoming IPO Click here.